Emory Global Health Institute names Dr. Michael H. Chung as new Associate Director

Michael Chung

Brings expertise in HIV chronic pulmonary disease, cardiovascular disease associated with COVID-19 infection, cervical cancer in HIV-positive women, and global health

The Emory Global Health Institute (EGHI) at Emory University has named Michael H. Chung, MD, PhD, MPH, as its new Associate Director. Dr. Chung succeeds Parminder S. Suchdev, MD, MPH, and will assume the post on March 1, 2022.

Dr. Chung currently serves as a Professor in the Division of Infectious Diseases of the Department of Medicine at Emory University School of Medicine and holds a joint appointment as Professor of Epidemiology and Professor of Global Health at Rollins School of Public Health.

He also is an Affiliate Professor in the Department of Global Health at the University of Washington and serves as Executive Director of the Treatment, Research, and Expert Education program.

"I am thrilled to have Michael join the Institute,” said Rebecca Martin, PhD, Vice President for Global Health at Emory University and the Director of EGHI. “He brings a wealth of global health experience, and he values an interdisciplinary approach to creating solutions to complex topics. I look forward to working with him in building the next generation of global health leaders."

Dr. Chung was based overseas for almost 20 years, implementing global health programs in Africa and Southeast Asia, before joining the faculty at Emory University. He spent several years living in Nairobi, Kenya, where he co-founded the Coptic Hope Center for Infectious Diseases and worked at the University of Nairobi and Kenyatta National Hospital. He also taught at Bach Mai Hospital and Hanoi Medical University in Hanoi, Vietnam.

After completing his medical degree at the University of Chicago and his Master of Public Health from Harvard T.H. Chan School of Public Health, Dr. Chung received his PhD from Ghent University in Ghent, Belgium.

His internship and residency in internal medicine were completed at Harvard Medical School, Beth Israel Deaconess Medical Center in Boston, and he completed his fellowship in infectious diseases at University of Washington in Seattle.

“It’s important to make a difference for the people who are living in low- or middle-income countries. I believe that EGHI is committed to addressing inequities in their health care, and to bringing more voices to the table that reflect the diversity of the world,” Dr. Chung said. “These perspectives are necessary if we want to bring about true change.”

Dr. Chung’s current research focuses on HIV chronic pulmonary disease, cardiovascular disease associated with COVID-19 infection, and the examination of cervical cancer screening and treatment among HIV-positive women.

Please welcome Dr. Chung to EGHI.

Share This Story